1. Advantages and problems of induced membrane technology in the treatment of infectious nonunion
Chinese Journal of Tissue Engineering Research 2020;25(10):1604-1608
BACKGROUND: The course of infectious bone nonunion is often difficult to heal and has a high risk of recurrence, which brings great trouble to patients’ lives. With the continuous research on the induced membrane technique, the advantages of the treatment of infectious nonunion with the induced membrane technique have gradually emerged and become a new research direction of medical work. OBJECTIVE: To explore the action mechanism of induced membrane technology in the treatment of infectious nonunion. METHODS: The relevant domestic and foreign literatures from 2013 to 2019 of PubMed, MEDLINE, Wanfang, CNKI, VIP, and Ubiquitous Chinese Biomedical Literature Database were retrieved. The key words were “induced membrane technique, infectious nonunion, induced membrane, growth factor” in Chinese and English. RESULTS AND CONCLUSION: The biological structure and function of the induced membrane are similar to that of the periosteum. It can induce the formation of osteoblasts and promote the growth of bone tissue. The induced membrane can secrete many kinds of growth factors, such as vascular endothelial growth factor, bone morphogenetic protein 2 and transforming growth factor β1. The application of induced membrane technology in clinic, especially in the field of fracture, has achieved remarkable results, which provides a new choice for the treatment of infectious nonunion. Exploring the most suitable stuffing material and bone grafting time and the dynamic ratio of the two have become the breakthrough point and challenge of this technology.
2.Treatment of intractable atlantoaxial dislocation with atlantoaxial pedicle screw instrumentation in children
Bin LIN ; Kejian LIAN ; Xiongwei DENG ; Zhimin GUO ; Hui LIU
Chinese Journal of Trauma 2008;24(8):608-611
Objective To explore the clinical effects of atlantoaxial pedicle screw instrumentation in treatment of intractable atlantoaxial dislocation in children. Methods A total of 7 patients with intractable atlantoaxial dislocations were treated with aflantoaxial pedicle screw instrumentation plus atlantoaxial bone grafting from June 2002 to January 2001. Results The dislocation in all patients reached complete reduction, with no complications. All patients were followed up for average 10 months (8-14 months). Radiographs showed successful bone fusion in all patients. Conclusion Atlantoaxial pedicle screw fixation and fusion is an effective method for treatment of intractable atlantoaxial dislocation in chil dren.
3.Study on delivery efficiency and cytotoxicity of Hela cells with mPEG-PLGA-BSA-FITC-NPs nanocarrier.
Zhiting CHEN ; Nan WU ; Xiongwei DENG ; Fangyuan WANG ; Kun LI ; Weiwei GUO ; Riyuan LIU ; Shuolong YUAN ; Jiakun ZHANG ; Shiming YANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2015;29(1):48-56
OBJECTIVE:
To construct and obtain ideal protein delivery vectors by researching the delivery efficiency and cytotoxicity to Hela cells using mPEG-PLGA-BSA-FITC-NPs.
METHOD:
The mPEG-PLGA nanoparticle was obtained through surface modification of PLGA with PEG, and deliver BSA-FITC into Hela cells in vitro. The positive cells were counted by Laser scanning confocal microscopy and the survival rate of Hela cells was calculated by MTT assay at different time points.
RESULT:
mPEG-PLGA-BSA-FITC-NPs shows the classic nanometer size, and the encapsulation efficiency reached 51. 2%. At the same time, the nanoparticles possess characteristics of slow release. By optimizing the delivery conditions, the highest efficiency of mPEG-PLGA-BSA-FITC-NPs was above 65.2%, and the cellular viability was about 85.7%.
CONCLUSION
mPEG-PLGA-BSA-FITC-NPs nanoparticles can successfully carry the target protein into cells as safe and effective as novel delivery materials of protein in vitro, and has shown slow release characteristics. The mPEG-PLGA-BSA-FITC-NPs provide ideal delivery vector for future application in clinical treatment of disease using nano-materials.
Drug Carriers
;
Fluorescein-5-isothiocyanate
;
analogs & derivatives
;
HeLa Cells
;
Humans
;
Nanoparticles
;
Particle Size
;
Polyesters
;
Polyethylene Glycols
;
Serum Albumin, Bovine
4.Study on effect of bevacizumab combined with chemotherapy on expression of serum EGFR and HER in patients with metastatic colorectal cancer
Lichun DENG ; uaming H SHENG ; Lei XI ; Xiongwei LIU ; Jie ZENG ; Xiangming CAO
Chongqing Medicine 2017;46(33):4659-4661
Objective To investigate the effect of bevacizumab combined with chemotherapy on the expression of EGFR and HER in the patients with metastatic colorectal cancer .Methods Sixty patients with metastatic colorectal cancer treated in this hos-pital from January 2013 to October 2016 were selected and randomly divided into the experiment group (bevacizumab combined with FOLFOX-6 chemotherapy regimen) and control group (FOLFOX-6 chemotherapy regimen) 30 cases in each group .The curative effects were observed in the two groups .The levels of serum HER and EGFR were detected by enzyme-linked immunosorbent assay (ELISA) .Results The total effective rate after treatment in the experiment group was 53 .33% ,which in the control group was 33 .33% ,the difference was statistically significant (P< 0 .05) .After treatment ,the levels of serum HER and EGHR in the two groups were decreased to some extent ,moreover the experiment group had more decrease than the control group ,the difference be-tween the two groups was statistically significant (P<0 .05) .The occurrence rate of adverse reactions had no statistical difference between the two groups (P>0 .05) .Conclusion Bevacizumab combined with chemotherapy has good effect in the patients with metastatic colorectal cancer .
5.Risk assessment of outcomes using grafts from donors after cardiac death
Xinguo CHEN ; Qing ZHANG ; Lihua YIN ; Wei LI ; Fengdong WU ; Weilong ZOU ; Yi WANG ; Xiongwei ZHU ; Hong CHEN ; Yang YUE ; Yonglin DENG ; Zhongyang SHEN
Chinese Journal of Organ Transplantation 2017;38(5):287-291
Objective To assess the effects of the risk factors of grafts from donors after cardiac death (DCD) on the prognosis of liver transplantation (LT).Methods In this retrospectively study,215 cases of LT using DCD donor grafts were performed at our institution from September 2013 to January 2017.Due to the loss to follow-up in 4 cases,211 cases were enrolled in the study.The following DCD donor data were collected:gender,age,primary disease,ABO blood type,body mass index (BMI),medical history (fatty liver,hypertension),ICU hospitalization time,mechanical ventilation time,warm ischemia time,cold ischemia time,and indexes of routine laboratory test before donation.Statistical analyses using the Kaplan-Meier method,log-rank test,multivariate step-wise Cox regression were performed.Results Of the 211 donors,univariate analysis showed that the overall 6-month,1-,and 3-year survival rate after DCD LT was 88%,84%,and 82%,respectively.Univariate analysis showed that donor serum sodium level <136 mmol/L (P =0.018) and cold ischemia time >9 h (P =0.013) were all significant risk factors affecting overall survival after DCD LT.Additionally,donor BMI >30 kg/m2 (P =0.011) and donor age >60 years (P =0.025) were significantly associated with postoperative complications.Multivariate analysis showed that donor serum sodium level (P=0.025) was an independent risk factor of survival after DCD LT.Conclusion To select suitable DCD liver allografts and control risk factors of donor can help to improve outcomes of recipients.
6.Establishment and application of a nomogram model for prognostic risk prediction in patients with epithelial ovarian cancer
Zhen LI ; Xiongwei CAI ; Ping YAN ; Dan ZHOU ; Mingmin HE ; Li DENG ; Yanzhou WANG ; Zhiqing LIANG
Chinese Journal of Obstetrics and Gynecology 2022;57(3):190-197
Objective:To explore the prognostic factors of epithelial ovarian carcinoma (EOC), construct a nomogram model, and evaluate the prognosis of EOC patients.Methods:A retrospective analysis was performed on clinicopathological data of 208 cases of EOC patients who received initial treatment in the First Affiliated Hospital of Army Medical University from August 11, 2016 to July 11, 2018, including age, preoperative ascites, preoperative neoadjuvant chemotherapy, surgical method, pathological type, pathological differentiation degree, surgical pathology stage, preoperative and post-chemotherapy serum cancer antigen 125 (CA 125) level, human epididymal protein 4 (HE4) level, platelet count and platelet/lymphocyte number ratio (PLR). The univariate and multivariate Cox risk ratio models were used to analyze the related factors affecting progression free survival (PFS) in EOC patients, and the prediction nomogram of PFS in EOC patients was established to evaluate its efficacy in predicting PFS. Results:Univariate analysis showed that preoperative neoadjuvant chemotherapy, pathological type, pathological differentiation degree, surgical pathology stage, serum CA 125 and HE4 level before operation and after chemotherapy, platelet count and PLR before operation and after chemotherapy were significantly correlated with PFS in EOC patients (all P<0.05). Multivariate analysis showed that surgical pathology stage, preoperative PLR, serum CA 125 and HE4 level after chemotherapy were independent prognostic factors affecting PFS of EOC patients (all P<0.01). The index coefficient of the prediction model for the prognosis of EOC patients established by this method was 0.749 (95% CI: 0.699-0.798), which had good prediction ability, and could help clinicians to more accurately evaluate the prognosis of EOC patients. Conclusion:The nomogram model constructed based on surgical pathology stage, preoperative PLR, serum CA 125 and HE4 level after chemotherapy could effectively predict the PFS of EOC patients after initial treatment, could help clinicians to screen high-risk patients, provide individualized treatment, and improve the prognosis of EOC patients.